
David F Putrino, PhD
About Me
Dr. David Putrino is an Official Medical Provider for Red Bull’s Sponsored Athletes in North America.
David has a PhD in Neuroscience. He worked as a clinician in Australia, before moving to the United States to study computational neuroscience at Harvard Medical School, MIT and NYU. He has served as a faculty member at Weill-Cornell Medicine and Burke Medical Research Institute.
He is currently the Director of Rehabilitation Innovation for the Mount Sinai Health System, and a Professor in the Department of Rehabilitation and Human Performance at the Icahn School of Medicine at Mount Sinai. He works to develop innovative technology solutions for individuals in need of better healthcare accessibility.
He consults with the Red Bull High Performance division to use evidence-based technologies to improve athletic performance. He is also the “Chief Mad Scientist” of Not Impossible Labs, a group that crowd-sources accessible technological solutions for high-impact humanitarian problems. David’s research has been featured on the ABC, Sport’s Illustrated, the Wall Street Journal, the BBC, Time, Wired and the LA Times to name just a few.
Language
English
Position
PROFESSOR | Rehabilitation and Human Performance
Research Topics
Cell Biology, Cognitive Neuroscience, Molecular Biology, Neurophysiology, Neuroscience
Education
PhD, The University of Western Australia
Publications
Selected Publications
- Long COVID clinical evaluation, research and impact on society: a global expert consensus. Andrew G. Ewing, David Joffe, Svetlana Blitshteyn, Anna E.S. Brooks, Julien Wist, Yaneer Bar-Yam, Stephane Bilodeau, Jennifer Curtin, Rae Duncan, Mark Faghy, Leo Galland, Etheresia Pretorius, Spela Salamon, Danilo Buonsenso, Claire Hastie, Binita Kane, M. Asad Khan, Amos Lal, Dennis Lau, Raina MacIntyre, Sammie McFarland, Daniel Munblit, Jeremy Nicholson, Hanna M. Ollila, David Putrino, Alberto Rosario, Timothy Tan. Annals of Clinical Microbiology and Antimicrobials
- Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial. Mitsuaki Sawano, Bornali Bhattacharjee, César Caraballo, Rohan Khera, Shu Xia Li, Jeph Herrin, Dany Christian, Andreas Coppi, Frederick Warner, Julie Holub, Yashira Henriquez, Maria A. Johnson, Theresa B. Goddard, Erica Rocco, Amy C. Hummel, Mohammad AL Mouslmani, William Brenham Hooper, David F. Putrino, Kevin D. Carr, Lawrence Charnas, Magdia De Jesus, Dale Nepert, Paula Abreu, Frank W. Ziegler, John A. Spertus, Akiko Iwasaki, Harlan M. Krumholz. The Lancet Infectious Diseases
- Development of a novel clinical outcome assessment: digital instrumental activities of daily living. Abbey Sawyer, Jamie Brannigan, Lisa Spielman, Andy Ho Wing Chan, Andy Wu, Betts Peters, Erin Switalski, Esmee Dohle, Franly Rosario, Hugo Layard Horsfall, Jimena Garcia-Vega, Jenna Tosto-Mancuso, Joshua McGrane, Kate Nilson, Leigh Hochburg, Luke McCarron, Maria Nardozzi, Mark Lillicrap, Martin Gould, Melanie Fried-Oken, Miguel Escalon, Nick Ramsey, Noam Harel, Pamela Roberts, Remi Rufus-Toye, Roger Smith, Ronnie Gross, Ryan Solinsky, Sandy Hannebrink, Sean Tunis, Sheng Li, Shelena Lalji, Steve Spohn, Suraya Yusuf, Sybil Stacpoole, Todd Little, William Muirhead, David Putrino, Adam Fry. eBioMedicine